Yesterday, Governor Andrew Cuomo (D-NY) announced that the Buffalo-based Roswell Park Cancer Institute will launch a groundbreaking clinical trial of CIMAvax-EGF – a Cuban-developed lung cancer treatment.
This announcement comes on the heels of recent Administration regulatory changes to Cuba sanctions that allow for increased medical collaboration between the U.S. and Cuba. As I'm sure you know, Cuba's healthcare system has achieved renown for its world-class doctors and medical breakthroughs. These changes are a step in the right direction in terms of increasing joint medical research, but only Congress can fully lift the embargo to permanently remove all restrictions on joint scientific and medical research.
"This groundbreaking clinical trial is just the beginning of what could be accomplished from a thriving medical partnership between Cuba and the United States," said President of Engage Cuba, James Williams. "While the Administration has taken steps to allow for increased medical collaboration, like this Roswell Park clinical trial of a Cuban-developed lung cancer treatment, there is no telling what life-saving treatments might be discovered if Congress lifts the U.S. embargo that is stifling innovation in healthcare."